Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DBOInvesco DB Oil Fund

NYSE · CIK 0001383058
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts155

Identity from submissions API

NameInvesco DB Oil Fund
CIK0001383058
TickersDBO
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC6221 Commodity Contracts Brokers & Dealers
EIN870778062
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone800-983-0903
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • PowerShares DB Oil Fund (2006-12-26T00:00:00.000Z → 2018-06-04T00:00:00.000Z)
Business address
3500 LACEY ROAD
SUITE 700
DOWNERS GROVE
IL
60515
IL
Mailing address
3500 LACEY ROAD
SUITE 700
DOWNERS GROVE
IL
60515
IL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

328 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 10-Q 10-Q 0001193125-26-450267 001-33242 261528753 34 7493673 1 1
2026-10-21 424B3 424B3 0001193125-26-427901 333-280609-01 261476088 33 9746
2026-10-21 8-K 8-K 5.02 0001193125-26-427828 001-33242 261475761 34 228525 1 1
2026-08-26 424B3 424B3 0001193125-26-368468 333-280609-01 261322972 33 1202057
2026-08-07 10-Q 10-Q 0001193125-26-338716 001-33242 261250947 34 10058876 1 1
2026-08-03 424B3 424B3 0001193125-26-330766 333-280609-01 261234005 33 8706
2026-08-03 8-K 8-K 5.02 0001193125-26-330606 001-33242 261233094 34 235361 1 1
2026-06-08 8-K 8-K 5.02 0001193125-26-260305 001-33242 261070845 34 224201 1 1
2026-05-07 10-Q 10-Q 0001193125-26-209732 001-33242 26950281 34 5942328 1 1
2026-03-27 424I 424I 0001104659-26-035914 333-280609-01 26803741 33 152073 1 1
2026-03-02 10-K 10-K 0001193125-26-083549 001-33242 26702651 34 8217270 1 1
2025-11-10 424B3 424B3 0001193125-25-273330 333-280609-01 251464467 33 1200022
2025-11-07 10-Q 10-Q 0001193125-25-270333 001-33242 251460024 34 10512299 1 1
2025-09-26 424B3 424B3 0001193125-25-218665 333-280609-01 251345486 33 6904
2025-09-26 8-K 8-K 8.01 0001193125-25-218562 001-33242 251345460 34 172483 1 1
2025-08-26 424B3 424B3 0001193125-25-188736 333-280609-01 251258131 33 1201435
2025-08-07 10-Q 10-Q 0000950170-25-105197 001-33242 251195039 34 10820350 1 1
2025-05-08 10-Q 10-Q 0000950170-25-067173 001-33242 25927265 34 7483478 1 1
2025-03-26 424I 424I 0001193125-25-063748 333-280609-01 25771550 33 47583
2025-02-26 10-K 10-K 0000950170-25-027272 001-33242 25665862 34 9143121 1 1
2024-11-12 424B3 424B3 0001193125-24-256090 333-280609-01 241449819 33 9657
2024-11-07 10-Q 10-Q 0000950170-24-122590 001-33242 241432578 34 7573549 1 1
2024-08-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-26 16:00:00 9999999995-24-002637 333-280609-01 241243092 33 3053
2024-08-26 424B3 424B3 0001193125-24-207155 333-280609-01 241242092 33 1200127
2024-08-22 CORRESP filename1.htm 0001193125-24-205308 10786
2024-08-20 S-3/A S-3/A 0001193125-24-203740 333-280609-01 241226235 33 1479783
2024-08-07 10-Q 10-Q 0000950170-24-092105 001-33242 241180852 34 7583868 1 1
2024-08-02 424B3 424B3 0001193125-24-192983 333-257268-01 241172414 33 8917
2024-08-02 8-K 8-K 5.02 0001193125-24-192958 001-33242 241172172 34 239704 1 1
2024-07-09 UPLOAD filename1.pdf 0000000000-24-007735 333-280609 41151
2024-06-28 S-3 S-3 0001193125-24-172440 333-280609-01 241087067 33 1309124
2024-05-08 10-Q 10-Q 0000950170-24-054959 001-33242 24923881 34 5727137 1 1
2024-03-22 424I 424I 0001193125-24-074740 333-257268-01 24773480 33 49195
2024-02-23 10-K 10-K 0000950170-24-019057 001-33242 24667040 34 7164471 1 1
2023-11-28 424B3 424B3 0001193125-23-284406 333-257268-01 231447617 33 8223
2023-11-28 8-K 8-K 5.02 0001193125-23-284398 001-33242 231447527 34 243738 1 1
2023-11-08 10-Q 10-Q 0000950170-23-060455 001-33242 231385308 34 8592289 1 1
2023-08-25 424B3 424B3 0001193125-23-221526 333-257268-01 231208574 33 1142858
2023-08-04 10-Q 10-Q 0000950170-23-038215 001-33242 231141641 34 9386178 1 1
2023-05-09 10-Q 10-Q 0000950170-23-018990 001-33242 23899404 34 6620255 1 1
2023-03-28 424B3 424B3 0001193125-23-082198 333-257268-01 23769848 33 5885
2023-03-24 424I 424I 0001193125-23-078890 333-257268-01 23759110 33 47136
2023-02-24 10-K 10-K 0001564590-23-002354 001-33242 23662018 34 7479046 1 1
2022-11-04 10-Q 10-Q 0001564590-22-036655 001-33242 221359426 34 7520756 1 1
2022-08-31 424I 424I 0001193125-22-235128 333-257268-01 221217723 33 42023
2022-08-25 424B3 424B3 0001193125-22-230016 333-257268-01 221197414 33 1129786
2022-08-05 10-Q 10-Q 0001564590-22-028072 001-33242 221138177 34 7512000 1 1
2022-05-06 10-Q 10-Q 0001564590-22-018353 001-33242 22898003 34 5711049 1 1
2022-03-03 424B3 424B3 0001193125-22-064006 333-257268-01 22707427 33 10433
2022-02-25 10-K 10-K 0001564590-22-006828 001-33242 22673391 34 7444123 1 1
2021-11-05 10-Q 10-Q 0001564590-21-054593 001-33242 211381369 34 7808926 1 1
2021-08-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-08-25 16:00:00 9999999995-21-003306 333-257268-01 211208692 33 2955
2021-08-25 424B3 424B3 0001193125-21-256394 333-257268-01 211207663 33 1125123
2021-08-23 CORRESP filename1.htm 0001193125-21-253872 9312
2021-08-17 S-3/A S-3/A 0001193125-21-249333 333-257268-01 211184044 33 1205422
2021-08-06 10-Q 10-Q 0001564590-21-041780 001-33242 211149909 34 7457830 1 1
2021-06-28 UPLOAD filename1.pdf 0000000000-21-007921 41183
2021-06-22 S-3 S-3 0001193125-21-195322 333-257268-01 211033182 33 1247362
2021-05-07 10-Q 10-Q 0001564590-21-025151 001-33242 21899359 34 5602328 1 1
2021-02-26 10-K 10-K 0001564590-21-009018 001-33242 21682381 34 7820004 1 1
2021-02-01 424B3 424B3 0001193125-21-024723 333-237802-01 21577650 33 7807
2020-11-06 10-Q 10-Q 0001564590-20-051531 001-33242 201291880 34 7831289 1 1
2020-10-30 424B3 424B3 0001193125-20-282647 333-237802-01 201277792 33 9298
2020-10-30 8-K 8-K 5.02 0001193125-20-282573 001-33242 201277524 34 294698 1 1
2020-10-23 8-K 8-K 5.02 0001193125-20-275486 001-33242 201257926 34 289034 1 1
2020-09-30 424B3 424B3 0001193125-20-259785 333-237802-01 201212854 33 6100
2020-09-30 8-K 8-K 1.01 0001193125-20-259663 001-33242 201212535 34 296008 1 1
2020-08-27 424B3 424B3 0001193125-20-233246 333-237802-01 201143874 33 931927
2020-08-07 10-Q 10-Q 0001564590-20-037953 001-33242 201083260 34 7262649 1 1
2020-06-02 424B3 424B3 0001193125-20-158372 333-237802-01 20936684 33 10547
2020-05-19 8-K 8-K 1.01,5.02,9.01 0001193125-20-146277 001-33242 20894857 34 419023 1 1
2020-05-11 424B3 424B3 0001193125-20-138789 333-237802-01 20864067 33 808835
2020-05-08 10-Q 10-Q 0001564590-20-023037 001-33242 20857924 34 5477568 1 1
2020-04-29 FWP FWP 0001193125-20-124815 333-237802-01 20827767 34 89618
2020-04-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-04-24 17:00:00 9999999995-20-000860 333-237802-01 20817053 33 2953
2020-04-24 424B3 424B3 0001193125-20-119244 333-237802-01 20815962 33 803842
2020-04-24 424B3 424B3 0001193125-20-119236 333-228404-02 20815929 33 11000
2020-04-24 CORRESP filename1.htm 0001193125-20-119061 12826
2020-04-24 S-3/A S-3/A 0001193125-20-119031 333-237802-01 20814920 33 880457
2020-04-22 S-3 S-3 0001193125-20-115108 333-237802-01 20809667 33 897727
2020-04-07 424B3 424B3 0001193125-20-100261 333-228404-02 20779185 33 17704
2020-04-02 8-K a8k.htm 5.02 0000929638-20-000501 001-33242 20770231 34 71990
2020-02-28 10-K 10-K 0001564590-20-007560 001-33242 20665020 34 6876403 1 1
2020-02-13 SC 13G/A SC 13G/A 0001193125-20-035560 005-83431 20610605 34 36681
2019-11-08 10-Q 10-Q 0001564590-19-042301 001-33242 191204604 34 6955458 1 1
2019-10-01 8-K 8-K 1.01,9.01 0001193125-19-259772 001-33242 191128852 34 807387 1 1
2019-08-27 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-19-220110,2019-08-27 9999999995-19-001965 333-228404-02 191059065 33 5761
2019-08-27 424B3 424B3 0001193125-19-230899 333-228404-02 191058085 33 1061887
2019-08-13 POS AM POS AM 0001193125-19-220110 333-228404-02 191021740 33 1204165
2019-08-08 10-Q 10-Q 0001564590-19-030305 001-33242 191007159 34 6122714 1
2019-06-05 424B3 424B3 0001193125-19-165734 333-228404-02 19879042 33 15641
2019-05-15 424B3 424B3 0001193125-19-147840 333-228404-02 19827095 33 2659820
2019-05-10 424B3 424B3 0001193125-19-144292 333-228404-02 19815258 33 12535
2019-05-10 8-K FORM 8-K 5.02 0001193125-19-144246 001-33242 19815006 34 64226
2019-05-09 10-Q 10-Q 0001564590-19-017400 001-33242 19808188 34 4651391 1
2019-04-25 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-19-102789,2019-04-25 9999999995-19-000825 333-228404-02 19769219 33 6674
2019-04-25 424B3 424B3 0001193125-19-119814 333-228404-02 19768094 33 2905867
2019-04-10 POS AM POS AM 0001193125-19-102789 333-228404-02 19741684 33 2773930
2019-03-05 424B3 424B3 0001193125-19-063405 333-228404-02 19656973 33 4460074
2019-02-28 10-K 10-K 0001564590-19-005096 001-33242 19640088 34 6024299 1
2019-02-12 SC 13G SC 13G 0001193125-19-035669 005-83431 19590181 34 36856
2018-12-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2018-12-13 16:00:00 9999999995-18-003125 333-228404-02 181234475 33 6667
2018-12-13 424B3 424B3 0001193125-18-348912 333-228404-02 181233774 33 3541362
2018-12-11 CORRESP filename1.htm 0001193125-18-346850 22938
2018-11-26 UPLOAD filename1.pdf 0000000000-18-036206 43683
2018-11-16 FWP FWP 0001193125-18-329078 333-209437-04 181190505 34 813976
2018-11-15 S-1 S-1 0001193125-18-328067 333-228404-02 181187781 33 3705662
2018-11-07 10-Q 10-Q 0001564590-18-027569 001-33242 181164174 34 5895387 1
2018-09-04 424B3 PROSPECTUS SUPPLEMENT NO. 4 0001193125-18-266336 333-209437-04 181053178 33 14106
2018-08-28 8-K FORM 8-K 5.02 0001193125-18-260020 001-33242 181040681 34 42582
2018-08-08 10-Q 10-Q 0001564590-18-020076 001-33242 18999400 34 5805268 1
2018-07-23 8-K FORM 8-K 5.02 0001193125-18-223835 001-33242 18965077 34 56246
2018-06-04 8-K FORM 8-K 5.03,9.01 0001193125-18-183427 001-33242 18878847 34 73559
2018-06-04 424B3 PROSPECTUS SUPPLEMENT NO. 3 0001193125-18-183222 333-209437-04 18878068 33 10835
2018-05-24 424B3 PROSPECTUS SUPPLEMENT NO. 2 0001193125-18-173654 333-209437-04 18858436 33 12583
2018-05-08 10-Q 10-Q 0001564590-18-011660 001-33242 18813923 34 4532939 1
2018-04-27 424B3 PROSPECTUS SUPPLEMENT 0001193125-18-138921 333-209437-04 18784091 33 24171
2018-03-08 8-K FORM 8-K 8.01,9.01 0001193125-18-075377 001-33242 18677385 34 42238
2018-03-08 424B3 424B3 0001193125-18-075356 333-209437-04 18677324 33 3081243
2018-02-28 10-K 10-K 0001564590-18-003594 001-33242 18647480 34 5484021 1
2017-11-22 424B3 424B3 0001193125-17-350557 333-209437-04 171219592 33 3814392
2017-11-09 10-Q 10-Q 0001564590-17-022866 001-33242 171187695 34 5397236 1
2017-08-08 10-Q 10-Q 0001564590-17-016089 001-33242 171012767 34 5397969 1
2017-05-08 10-Q DBO-Q1-20170331 0001564590-17-009465 001-33242 17823610 34 5228028 1
2017-03-10 424B3 PROSPECTUS 0001193125-17-078614 333-209437-04 17681648 33 3804497
2017-03-01 10-K DBO-10K-20161231 0001564590-17-002926 001-33242 17650095 34 6329084 1
2016-11-29 424B3 PROSPECTUS 0001193125-16-779726 333-209437-04 162023413 33 3798227
2016-11-08 10-Q DBO-Q3-20160930 0001564590-16-028281 001-33242 161981167 34 5734746 1
2016-08-09 10-Q DBO-Q2-20160630 0001564590-16-023715 001-33242 161818581 34 5596671 1
2016-06-21 424B3 PROSPECTUS 0001193125-16-626840 333-209437-04 161723237 33 3488202
2016-06-20 8-K FORM 8-K 1.01,5.03,9.01 0001193125-16-626572 001-33242 161722774 34 104416
2016-05-10 10-Q 10-Q 0001564590-16-018910 001-33242 161635584 34 4549428 1
2016-04-22 8-K FORM 8-K 1.02 0001193125-16-551880 001-33242 161586439 34 35330
2016-03-25 424B3 SUPPLEMENT 0001193125-16-517119 333-209437-04 161528242 33 28347
2016-03-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2016-03-04 13:00:00 9999999995-16-003892 333-209437-04 161486833 33 6071
2016-03-04 424B3 424B3 0001193125-16-493075 333-209437-04 161484588 33 3722947
2016-03-03 CORRESP filename1.htm 0001193125-16-491690 12245
2016-03-03 S-3/A FORM S-3/A 0001193125-16-490456 333-209437-04 161479257 33 3829342
2016-02-29 IRANNOTICE IRANNOTICE 0001193125-16-482740 001-33242 161464120 34 7904
2016-02-29 10-K FORM 10-K 0001193125-16-482716 001-33242 161464100 34 3778112 1
2016-02-19 CORRESP filename1.htm 0001193125-16-470173 12492
2016-02-17 UPLOAD filename1.pdf 0000000000-16-065195 157638
2016-02-12 SC 13G/A SC 13G/A 0001193125-16-461880 005-83431 161417629 34 29476
2016-02-09 S-3 S-3 0001193125-16-454182 333-209437-04 161396921 33 3903104
2015-11-06 IRANNOTICE IRANNOTICE 0001193125-15-370361 001-33242 151213220 34 7347
2015-11-06 10-Q FORM 10-Q 0001193125-15-370090 001-33242 151207699 34 3532558 1
2015-08-10 IRANNOTICE IRANNOTICE 0001193125-15-284883 001-33242 151040933 34 6574
2015-08-10 10-Q FORM 10-Q 0001193125-15-284630 001-33242 151040314 34 3801606 1
2015-05-11 IRANNOTICE IRANNOTICE 0001193125-15-182051 001-33242 15851171 34 6887
2015-05-11 10-Q FORM 10-Q 0001193125-15-181976 001-33242 15850949 34 4138076 1
2015-03-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2015-03-30 16:00:00 9999999995-15-000728 333-203008-04 15736306 33 6235
2015-03-30 424B3 424B3 0001193125-15-111747 333-203008-04 15734598 33 3368471
2015-03-26 S-3 FORM S-3 0001193125-15-105419 333-203008-04 15725933 33 3538287
2015-03-09 IRANNOTICE IRANNOTICE 0001193125-15-081330 001-33242 15682854 34 7656
2015-03-06 10-K FORM 10-K 0001193125-15-081289 001-33242 15682679 34 4928028 1
2015-02-26 8-K FORM 8-K 8.01 0001193125-15-064156 001-33242 15650268 34 31487
2015-02-26 424B3 424B3 0001193125-15-064064 333-193221-03 15650183 33 3372314
2015-02-26 8-K FORM 8-K 1.01,9.01 0001193125-15-063995 001-33242 15650101 34 225905
2015-02-25 RW RW 0001193125-15-062557 333-193221-03 15648052 NE 11996
2015-02-25 8-K FORM 8-K 5.01,5.03,5.07,8.01,9.01 0001193125-15-060654 001-33242 15645760 34 878010
2015-01-29 POS AM POS AM TO FORM S-3 0001193125-15-025824 333-193221-03 15559855 33 3794038
2015-01-23 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-15-019050 001-33242 15546424 34 722030
2015-01-23 CORRESP filename1.htm 0001193125-15-019029 52689
2015-01-23 UPLOAD filename1.pdf 0000000000-15-003435 40195
2015-01-09 CORRESP filename1.htm 0001193125-15-006769 213269
2014-12-23 UPLOAD filename1.pdf 0000000000-14-066628 158278
2014-12-16 CORRESP filename1.htm 0001193125-14-443872 34900
2014-12-08 POS AM POS AM TO FORM S-3 0001193125-14-436517 333-193221-03 141273182 33 3693067
2014-12-02 8-K FORM 8-K 8.01,9.01 0001193125-14-431092 001-33242 141261180 34 151875
2014-11-26 PRE 14A PRELIMINARY PROXY STATEMENT 0001193125-14-427274 001-33242 141254173 34 821724
2014-11-05 IRANNOTICE IRANNOTICE 0001193125-14-398300 001-33242 141196651 34 6232
2014-11-05 10-Q FORM 10-Q 0001193125-14-398172 001-33242 141196457 34 3804013 1
2014-10-30 8-K FORM 8-K 5.01,9.01 0001193125-14-387654 001-33242 141181282 34 86886
2014-08-15 8-K FORM 8-K 8.01,9.01 0001193125-14-311701 001-33242 141046460 34 146555
2014-08-06 IRANNOTICE IRANNOTICE 0001193125-14-298424 001-33242 141020719 34 6684
2014-08-06 10-Q FORM 10-Q 0001193125-14-298282 001-33242 141020253 34 3636557 1
2014-07-30 424B3 PROSPECTUS SUPPLEMENT 0001193125-14-286648 333-193221-03 141002514 33 2004818
2014-06-11 8-K FORM 8-K 8.01,9.01 0001193125-14-233575 001-33242 14905398 34 146032
2014-05-09 IRANNOTICE IRANNOTICE 0001193125-14-191952 001-33242 14828084 34 6126
2014-05-09 10-Q FORM 10-Q 0001193125-14-191863 001-33242 14827932 34 3095306 1
2014-03-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2014-03-14 10:00:00 9999999995-14-000666 333-193221-03 14696008 33 6235
2014-03-14 424B3 424B3 0001193125-14-099882 333-193221-03 14694296 33 3033472
2014-03-13 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001193125-14-097924 333-193221-03 14691689 33 3246811
2014-03-13 8-K FORM 8-K 8.01,9.01 0001193125-14-097582 001-33242 14690934 34 154685
2014-03-04 IRANNOTICE IRANNOTICE 0001193125-14-080715 001-33242 14661842 34 6095
2014-03-03 10-K FORM 10-K 0001193125-14-080640 001-33242 14661660 34 4115676 1
2014-02-13 SC 13G POWERSHARES DB OIL FUND 0001193125-14-048493 005-83431 14601727 34 30442
2014-01-28 FWP FWP 0001193125-14-023646 333-184947-06 14551443 34 220139
2014-01-15 8-K FORM 8-K 8.01 0001193125-14-012099 001-33242 14530089 34 39764
2014-01-07 S-3 FORM S-3 0001193125-14-004290 333-193221-03 14514263 33 3250027
2013-12-04 8-K FORM 8-K 8.01,9.01 0001193125-13-461568 001-33242 131256172 34 136513
2013-11-05 IRANNOTICE IRANNOTICE 0001193125-13-427972 001-33242 131193725 34 6617
2013-11-05 10-Q FORM 10-Q 0001193125-13-427845 001-33242 131193259 34 3422445 1
2013-10-04 8-K 8-K 8.01,9.01 0001193125-13-391572 001-33242 131136710 34 134153
2013-08-08 IRANNOTICE IRANNOTICE 0001193125-13-326868 001-33242 131022403 34 6525
2013-08-08 10-Q FORM 10-Q 0001193125-13-326776 001-33242 131021814 34 4721111 1
2013-06-21 424B3 424B3 0001193125-13-267530 333-184947-06 13927545 33 2461939
2013-05-30 8-K FORM 8-K 4.01,9.01 0001193125-13-240753 001-33242 13880294 34 51172
2013-05-24 8-K FORM 8-K 8.01,9.01 0001193125-13-234982 001-33242 13870779 34 167451
2013-05-03 IRANNOTICE IRANNOTICE 0001193125-13-199393 001-33242 13813519 34 6983
2013-05-03 10-Q FORM 10-Q 0001193125-13-199311 001-33242 13813262 34 2611281 1
2013-03-29 IRANNOTICE IRANNOTICE 0001193125-13-134656 001-33242 13728137 34 7111
2013-03-29 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001193125-13-134607 001-33242 13728028 34 52135
2013-03-21 8-K FORM 8-K 8.01,9.01 0001193125-13-117704 001-33242 13706135 34 175365
2013-03-01 10-K FORM 10-K 0001193125-13-086681 001-33242 13655512 34 4341354 1
2013-01-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2013-01-03 15:00:00 9999999995-13-000109 333-184947-06 13509677 33 7086
2013-01-03 424B3 PROSPECTUS 0001193125-13-002253 333-184947-06 13506217 33 3998005
2013-01-02 S-3/A PRE-EFFECTIVE AMENDMENT NO.1 TO FORM S-3 0001193125-13-000842 333-184947-06 13501683 33 4814273
2012-12-07 8-K FORM 8-K 8.01 0001193125-12-495530 001-33242 121250882 34 39010
2012-11-16 8-K FORM 8-K 8.01,9.01 0001193125-12-473837 001-33242 121211055 34 167061
2012-11-14 S-3 FORM S-3 0001193125-12-470841 333-184947-06 121205390 33 4828115
2012-11-02 10-Q FORM 10-Q 0001193125-12-448423 001-33242 121175690 34 3444532 1
2012-09-17 424B3 SUPPLEMENT 0001193125-12-394053 333-163453-14 121095247 33 18877
2012-09-17 8-K FORM 8-K 5.02 0001193125-12-394025 001-33242 121095169 34 49813
2012-08-17 8-K FORM 8-K 8.01,9.01 0001193125-12-360166 001-33242 121041789 34 169446
2012-08-03 10-Q FORM 10-Q 0001193125-12-334219 001-33242 121006165 34 3322047 1
2012-05-24 8-K FORM 8-K 8.01,9.01 0001193125-12-246636 001-33242 12866631 34 162694
2012-05-14 10-Q FORM 10-Q 0001193125-12-229660 001-33242 12836504 34 2177987 1
2012-05-11 NT 10-Q FORM 12B-25 0001193125-12-228684 001-33242 12835609 34 21676
2012-05-01 424B3 FINAL PROSPECTUS 0001193125-12-197563 333-163453-14 12797637 33 5001088
2012-03-28 8-K FORM 8-K 8.01,9.01 0001193125-12-137225 001-33242 12720605 34 170172
2012-03-14 10-K FORM 10-K 0001193125-12-114472 001-33242 12689862 34 2711422 1
2011-12-07 8-K FORM 8-K 8.01 0001193125-11-333662 001-33242 111248909 34 39044
2011-11-21 8-K FORM 8-K 8.01,9.01 0001193125-11-318350 001-33242 111218771 34 168850
2011-11-07 10-Q FORM 10-Q 0001193125-11-299207 001-33242 111183684 34 2504211 1
2011-08-29 8-K FORM 8-K 8.01,9.01 0001193125-11-235547 001-33242 111063290 34 168244
2011-08-05 424B3 SUPPLEMENT DATED JULY 31, 2011 TO PROSPECTUS DATED JANUARY 3, 2011 0001193125-11-212215 333-163453-14 111014152 33 3529434
2011-08-05 10-Q FORM 10-Q 0001193125-11-211355 001-33242 111012188 34 2406171 1
2011-06-16 FWP FREE WRITING PROSPECTUS 0001193125-11-166508 333-163453-14 11914825 34 936106
2011-05-27 8-K FORM 8-K 8.01,9.01 0001193125-11-153053 001-33242 11877300 34 163293
2011-05-06 10-Q FORM 10-Q 0001193125-11-130324 001-33242 11818387 34 639955
2011-03-30 8-K FORM 8-K 8.01,9.01 0001193125-11-082972 001-33242 11722555 34 192873
2011-03-14 10-K FORM 10-K 0001193125-11-065728 001-33242 11685489 34 1126327
2011-02-09 SC 13G/A v210648_sc13g-a.htm 0001144204-11-007023 005-83431 11588116 34 81305
2011-01-05 SC 13G v207378_sc13g.htm 0001144204-11-000754 005-83431 11510367 34 81297
2011-01-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-11-000134,2011-01-03 9999999995-11-000036 333-163453-14 11503205 33 8372
2011-01-03 424B3 PROSPECTUS 0001193125-11-000446 333-163453-14 11502688 33 3983042
2011-01-03 CORRESP filename1.htm 0001193125-11-000329 13536
2011-01-03 8-K FORM 8-K 5.03,8.01 0001193125-11-000168 001-33242 11500362 34 53160
2011-01-03 POS AM POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-3 0001193125-11-000134 333-163453-14 11500177 33 1054071
2010-12-10 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 0001193125-10-278529 333-163453-14 101245875 33 4764238
2010-12-07 8-K FORM 8-K 8.01 0001193125-10-275661 001-33242 101237709 34 70921
2010-12-03 UPLOAD filename1.pdf 0000000000-10-072381 73669
2010-11-12 POS AM POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 0001193125-10-256487 333-163453-14 101181634 33 4181372
2010-11-08 8-K FORM 8-K 8.01,9.01 0001193125-10-251547 001-33242 101171337 34 205133
2010-11-05 10-Q FORM 10-Q 0001193125-10-249611 001-33242 101167635 34 1293282
2010-10-01 424B3 PROSPECTUS SUPPLEMENT 0001193125-10-222042 333-163453-14 101102328 33 3303277
2010-10-01 8-K FORM 8-K 8.01,9.01 0001193125-10-221931 001-33242 101101824 34 195899
2010-08-12 UPLOAD filename1.pdf 0000000000-10-046321 306522
2010-08-06 10-Q FORM 10-Q 0001193125-10-181105 001-33242 10997772 34 1223936
2010-07-16 UPLOAD filename1.pdf 0000000000-10-040234 41174
2010-06-25 10-Q/A FORM 10-Q/A 0001193125-10-147244 001-33242 10917478 34 843463
2010-06-18 10-K/A FORM 10-K/A 0001193125-10-142334 001-33242 10906427 34 1461885
2010-06-11 CORRESP filename1.htm 0001193125-10-137916 141062
2010-06-03 UPLOAD filename1.pdf 0000000000-10-030984 40624
2010-05-28 UPLOAD filename1.pdf 0000000000-10-030016 44774
2010-05-24 8-K FORM 8-K 8.01,9.01 0001193125-10-127189 001-33242 10853926 34 222850
2010-05-10 10-Q FORM 10-Q 0001193125-10-114680 001-33242 10816775 34 619952
2010-04-15 SC 13G v181118_sc-13g.htm 0001144204-10-020622 005-83431 10752940 34 80416
2010-03-30 8-K FORM 8-K 8.01,9.01 0001193125-10-071696 001-33242 10714836 34 197839
2010-03-08 10-K FORM 10-K 0001193125-10-049908 001-33242 10663117 34 1172644
2010-03-01 CORRESP filename1.htm 0001193125-10-044530 61986
2010-03-01 CORRESP filename1.htm 0001193125-10-044520 181360
2010-02-16 SC 13G v174317_sc13g.htm 0001144204-10-007516 005-83431 10601749 34 79170
2010-02-16 SC 13G v174315_sc13g.htm 0001144204-10-007507 005-83431 10601714 34 90018
2010-01-22 UPLOAD filename1.pdf 0000000000-10-004177 30261
2010-01-07 424B3 PROSPECTUS DATED JANUARY 4, 2010 0001193125-10-002243 333-163453-14 10513445 33 4023767
2010-01-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2010-01-04 09:30:00 9999999995-10-000030 333-163453-14 10504096 33 14934
2009-12-11 8-K FORM 8K 8.01 0001193125-09-251552 001-33242 091236652 34 81389
2009-12-03 8-K FORM 8-K 8.01 0001193125-09-246093 001-33242 091218605 34 72068
2009-12-03 S-3 FORM S-3 0001193125-09-246082 333-163453-14 091218552 33 5089508
2009-11-13 SC 13G v165684_sc13g.htm 0001144204-09-059077 005-83431 091182451 34 87372
2009-11-10 8-K FORM 8-K 8.01,9.01 0001193125-09-230883 001-33242 091173008 34 205406
2009-11-06 10-Q FORM 10-Q 0001193125-09-227656 001-33242 091165338 34 740521
2009-10-19 424B3 SUPPLEMENT DATED OCTOBER 19, 2009 TO PROSPECTUS DATED MAY 1, 2009 0001193125-09-209579 333-150501-15 091125856 33 2812017
2009-08-26 CORRESP filename1.htm 0001193125-09-182173 273466
2009-08-10 UPLOAD filename1.pdf 0000000000-09-043138 37423
2009-08-07 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2009 0001193125-09-168565 001-33242 09994169 34 830458
2009-06-08 8-K FORM 8-K 8.01 0001193125-09-127087 001-33242 09880224 34 32828
2009-05-14 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2009 0001193125-09-111269 001-33242 09826266 34 588573
2009-05-01 424B3 PROSPECTUS DATED MAY 1, 2009 0001193125-09-094831 333-150501-15 09785874 33 2967741
2009-04-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-09-079834,2009-04-30 9999999995-09-001129 333-150501-15 09786451 33 14947
2009-04-16 424B3 SUPPLEMENT DATED APRIL 10, 2009 TO PROSPECTUS DATED JULY 14, 2008 0001193125-09-080728 333-150501-15 09754069 33 2270959
2009-04-15 POS AM POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001193125-09-079834 333-150501-15 09752168 33 3147424
2009-04-14 424B3 SUPPLEMENT DATED APRIL 8, 2009 TO PROSPECTUS DATED JULY 14, 2008. 0001193125-09-077961 333-150501-15 09747312 33 21842
2009-04-07 8-K FORM 8-K 8.01,9.01 0001193125-09-073964 001-33242 09736154 34 195124
2009-03-31 8-K FORM 8-K 5.02 0001193125-09-069456 001-33242 09719483 34 66746
2009-03-10 10-K FORM 10-K 0001193125-09-049814 001-33242 09670021 34 962656
2008-12-01 CERTPAC AUTO-GENERATED PAPER DOCUMENT 9999999997-08-046974 001-33242 08018132 34 1734
2008-11-21 8-A12B efc8-1513_emailform8a12b.htm 0000905148-08-004858 001-33242 081207771 34 58409
2008-11-21 25 efc8-1527_emailform25.htm 0000905148-08-004827 001-33242 081207477 34 25765
2008-11-10 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30,2008 0001193125-08-230224 001-33242 081172806 34 761927
2008-08-08 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30,2008 0001193125-08-170557 001-33242 081000224 34 711756
2008-07-15 424B3 PROSPECTUS DATED JULY 14, 2008 0001193125-08-151308 333-150501-15 08953360 33 3917849
2008-07-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2008-07-14 09:30:00 9999999995-08-002183 333-150501-15 08951815 33 14934
2008-06-25 S-1/A PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001193125-08-139858 333-150501-15 08915674 33 4311105
2008-06-24 424B3 SUPPLEMENT DATED JUNE 20, 2008 TO PROSPECTUS DATED JANUARY 15, 2008 0001193125-08-139346 333-142163-14 08915037 33 23113
2008-06-23 8-K FORM 8-K 5.02 0001193125-08-138312 001-33242 08912839 34 80704
2008-05-14 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2008 0001193125-08-114369 001-33242 08830768 34 575133
2008-04-29 S-1 FORM S-1 0001193125-08-095205 333-150501-15 08786142 33 6868757
2008-04-11 8-K FORM 8-K 5.02 0001193125-08-079669 001-33242 08751793 34 71575
2008-03-26 10-K FORM 10-K 0001193125-08-065245 001-33242 08710803 34 687190
2008-03-05 424B3 PROSPECTUS SUPPLEMENT 0001193125-08-047980 333-142163-14 08668742 33 25446
2008-02-20 8-K CURRENT REPORT 8.01 0001193125-08-034567 001-33242 08630316 34 163838
2008-02-19 424B3 SUPPLEMENT DATED FEBRUARY 19, 2008 TO PROSPECTUS DATED JANUARY 15, 2008 0001193125-08-033741 333-142163-14 08627426 33 101929
2008-01-16 424B3 PROSPECTUS 0001193125-08-007382 333-148613-04 08533501 33 4867696
2008-01-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2008-01-15 12:00:00 9999999995-08-000157 333-148613-04 08532360 33 14934
2008-01-11 S-1 FORM S-1 0001193125-08-005420 333-148613-04 08526361 33 5086237
2008-01-11 SC 13G 12/31/2007 YEAR END FINAL 0001074683-08-000012 005-83431 08526174 34 27409
2008-01-11 SC 13G 12/31/2007 FINAL 0001074683-08-000014 005-83431 08526109 34 27400
2007-12-11 SC 13G 11/30/07 13G 0001074683-07-000581 005-83431 071298483 34 27689
2007-11-13 10-Q FORM 10-Q 0001193125-07-245012 001-33242 071237369 34 505293
2007-08-14 10-Q FORM 10-Q 0001193125-07-182334 001-33242 071053452 34 531600
2007-05-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2007-05-15 14:00:00 9999999995-07-001964 333-142163-14 07855770 33 14888
2007-05-15 424B3 FINAL PROSPECTUS 0001193125-07-115781 333-142163-14 07854342 33 3360416
2007-05-15 10-Q FORM 10-Q 0001193125-07-114996 001-33242 07850567 34 329521
2007-04-17 S-1 FORM S-1 0001193125-07-082015 333-142163-14 07769346 33 3501543
2007-04-10 424B3 SUPPLEMENT DATED APRIL 9, 2007 TO PROSPECTUS DATED JANUARY 3, 2007 0001193125-07-078071 333-135422-13 07759542 33 21306
2007-04-10 8-K FORM 8-K 5.02 0001193125-07-077995 001-33242 07759169 34 64450
2007-02-02 424B3 PROSPECTUS SUPPLEMENT 0001193125-07-019329 333-135422-13 07577055 33 44446
2007-01-26 8-K FORM 8-K 8.01 0001193125-07-014231 001-33242 07556830 34 66104
2007-01-26 424B3 PROSPECTUS SUPPLEMENT 0001193125-07-014214 333-135422-13 07556630 33 18630
2007-01-04 CERTAMX AUTO-GENERATED PAPER DOCUMENT 9999999997-07-000252 001-33242 07030003 34 1659
2007-01-03 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2007-01-03 09:45:00 9999999995-07-000032 333-135422-13 07506988 33 14566
2007-01-03 8-A12B FORM 8-A 0001193125-07-000701 001-33242 07504470 34 22521
2007-01-03 424B3 PROSPECTUS 0001193125-07-000624 333-135422-13 07503789 33 3748474
2006-12-26 CORRESP filename1.htm 0001193125-06-259962 26129
2006-12-26 S-1/A PRE-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 0001193125-06-259862 333-135422-13 061299223 33 3878348

Latest XBRL company facts

One latest value per concept from companyfacts (155 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 11.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
dei EntityPublicFloat Entity Public Float USD 228.04M 2025-06-30 2025 FY 10-K 2026-03-02 0001193125-26-083549
invest DerivativeNotionalAmount Derivative, Notional Amount USD 5.00M 2013-03-31 2013 Q1 10-Q 2013-05-03 0001193125-13-199311
srt PayablesToBrokerDealersAndClearingOrganizations Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization USD 3.37M 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-338716
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 378,156 2015-06-30 2015 Q2 10-Q 2015-08-10 0001193125-15-284630
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 15.94M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023037
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 614.36M 2012-09-30 2012 Q3 10-Q 2012-11-02 0001193125-12-448423
us-gaap AssetManagementCosts Asset Management Costs (Deprecated 2018-01-31) USD 2.94M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap Assets Assets USD 261.03M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 0 2014-12-31 2015 FY 10-K 2016-02-29 0001193125-16-482716
us-gaap AssetsUnderManagementCarryingAmount Assets under Management, Carrying Amount USD 101.68M 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-482716
us-gaap Cash Cash USD 1.04M 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 47.61M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023715
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 15.44M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023715
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.24M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-06 0001564590-21-041780
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 12.88M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001564590-20-037953
us-gaap CashSegregatedUnderCommodityExchangeActRegulation Cash Segregated under Commodity Exchange Act Regulation USD 68.61M 2014-12-31 2016 FY 10-K 2017-03-01 0001564590-17-002926
us-gaap CommissionsPayableToBrokerDealersAndClearingOrganizations Commissions Payable to Broker-Dealers and Clearing Organizations USD 4,915 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap Deposits Deposits USD 19.44M 2014-09-30 2014 Q3 10-Q 2014-11-05 0001193125-14-398172
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap DerivativeAssetFairValueGrossLiability Derivative Asset, Fair Value, Gross Liability USD 0 2014-06-30 2014 Q2 10-Q 2014-08-06 0001193125-14-298282
us-gaap DerivativeCollateralRightToReclaimCash Derivative, Collateral, Right to Reclaim Cash USD 0 2014-06-30 2014 Q2 10-Q 2014-08-06 0001193125-14-298282
us-gaap DerivativeCollateralRightToReclaimSecurities Derivative, Collateral, Right to Reclaim Securities USD 0 2014-06-30 2014 Q2 10-Q 2014-08-06 0001193125-14-298282
us-gaap DerivativeFairValueAmountOffsetAgainstCollateralNet Derivative, Fair Value, Amount Offset Against Collateral, Net USD -239,810 2013-12-31 2014 Q1 10-Q 2014-05-09 0001193125-14-191863
us-gaap DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset USD 13.05M 2014-06-30 2014 Q2 10-Q 2014-08-06 0001193125-14-298282
us-gaap DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral Derivative Asset, Fair Value, Amount Not Offset Against Collateral USD 13.05M 2014-06-30 2014 Q2 10-Q 2014-08-06 0001193125-14-298282
us-gaap DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral Derivative Asset, Fair Value, Amount Offset Against Collateral USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral Derivative Liability, Fair Value, Amount Offset Against Collateral USD 119.29M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap DistributedEarnings Distributed Earnings USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap DividendIncomeOperating Dividend Income, Operating USD 6.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 159,628 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027272
us-gaap DividendsReceivable Dividends Receivable USD 654,227 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap DueFromAffiliates Due from Affiliates USD 27,384 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042301
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 159,023 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-018990
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.62 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001564590-17-016089
us-gaap FinancialInstrumentsOwnedAtFairValue Financial Instruments, Owned, at Fair Value USD 297.52M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap FinancialInstrumentsOwnedDerivativesAndOtherContractualAgreementsAtFairValue Financial Instruments, Owned, Derivatives and Other Contractual Agreements, at Fair Value USD 14.57M 2013-09-30 2013 Q3 10-Q 2013-11-05 0001193125-13-427845
us-gaap FinancialInstrumentsOwnedOtherAtFairValue Financial Instruments, Owned, Other, at Fair Value USD 4.75M 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-105197
us-gaap FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue Financial Instruments, Owned, US Government and Agency Obligations, at Fair Value USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap FloorBrokerageExchangeAndClearanceFees Floor Brokerage, Exchange and Clearance Fees USD 79,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 115.10M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-027569
us-gaap GainLossOnSaleOfCommodityContracts Gain (Loss) on Sale of Commodity Contracts USD 135.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap GainLossOnSaleOfDebtInvestments Gain (Loss) on Sale of Debt Investments USD 5,557 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-03 0001193125-13-199311
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD -59.22M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -100,756 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-23 0000950170-24-019057
us-gaap GainLossOnSaleOfSecuritiesNet Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) USD 1,868 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap GeneralPartnersCapitalAccount General Partners' Capital Account USD 949 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap GeneralPartnersCapitalAccountUnitsOutstanding General Partners' Capital Account, Units Outstanding shares 40 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap GoodFaithAndMarginDepositsWithBrokerDealers Good Faith and Margin Deposits with Broker-Dealers USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 147,110 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 29,290 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -2,387 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-06 0001193125-14-298282
us-gaap IncreaseDecreaseInBrokerageReceivables Increase (Decrease) in Receivables from Brokers-Dealers and Clearing Organizations USD -4.67M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-10 0001564590-16-018910
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -7.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap IncreaseDecreaseInDividendsReceivable Increase (Decrease) in Dividends Receivable USD 202,326 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD -84.00M 2015-10-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-482716
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 4.00M 2010-01-01 2010-06-30 2011 Q2 10-Q 2011-08-05 0001193125-11-211355
us-gaap IncreaseDecreaseInPayableForInvestmentPurchased IncreaseDecreaseInPayableForInvestmentPurchased USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-338716
us-gaap IncreaseDecreaseInPayablesToBrokerDealers Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InterestAndDividendIncomeOperating Interest and Dividend Income, Operating USD 7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InterestExpense Interest Expense USD 86,291 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122590
us-gaap InterestExpenseOperating InterestExpenseOperating USD 88,498 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -837 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020076
us-gaap InterestIncomeOperating Interest Income, Operating USD 613,869 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 511 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011660
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 88,498 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyContractualFeeWaived Investment Company, Contractual Fee Waived USD 176,485 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver Investment Company, Expense Ratio Including Voluntary Fee Waiver pure 0.008 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyGainLossOnInvestmentPerShare Investment Company, Gain (Loss) on Investment, Per Share USD/shares 11.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyGeneralPartnerAdvisoryService Investment Company, General Partner Advisory Service USD 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare Investment Company, Investment Income (Loss) from Operations, Per Share USD/shares 11.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares 0.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure 0.028 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency USD 182.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentCompanyTaxReturnOfCapitalDistributionPerShare Investment Company, Tax Return of Capital Distribution, Per Share USD/shares -0.43 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure 0.946 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentIncomeNet Investment Income, Net USD -3.04M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 53.45M 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 256.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 1.009 2023-06-30 2023 Q2 10-Q 2023-08-04 0000950170-23-038215
us-gaap InvestmentOwnedUnderlyingFaceAmountAtMarketValue Investment Owned, Face Amount USD 465.10M 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080640
us-gaap InvestmentOwnedUnrecognizedUnrealizedAppreciation Investment Owned, Unrecognized Unrealized Appreciation USD 23.39M 2024-03-31 2024 Q1 10-Q 2024-05-08 0000950170-24-054959
us-gaap InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet Investment Owned, Unrecognized Unrealized Appreciation (Depreciation), Net USD 105.53M 2016-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003594
us-gaap InvestmentOwnedUnrecognizedUnrealizedDepreciation Investment Owned, Unrecognized Unrealized Depreciation USD 827,832 2023-12-31 2024 Q1 10-Q 2024-05-08 0000950170-24-054959
us-gaap InvestmentsInAndAdvancesToAffiliatesAtFairValue Investments in and Advances to Affiliates, at Fair Value USD 172.82M 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-018990
us-gaap Liabilities Liabilities USD 144,985 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 261.03M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap LimitedPartnersCapitalAccount Limited Partners' Capital Account USD 260.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap LimitedPartnersCapitalAccountUnitsOutstanding Limited Partners' Capital Account, Units Outstanding shares 11.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap ManagementFeePayable Management Fee Payable USD 144,985 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 270 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-23 0000950170-24-019057
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 135.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -6.70M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122590
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 1,128 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-01 0001193125-13-086681
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 23.72 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -132.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -34.63M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011660
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 132.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 33.62M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011660
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 188.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 28 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-01 0001193125-13-086681
us-gaap OperatingExpenses Operating Expenses USD 1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 5.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap PartnersCapitalAccountContributions Partners' Capital Account, Contributions USD 1,000 2015-02-22 2015-02-23 2017 FY 10-K 2018-02-28 0001564590-18-003594
us-gaap PartnersCapitalAccountReturnOfCapital Partners' Capital Account, Return of Capital USD 7.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap PartnersCapitalAccountUnits Partners' Capital Account, Units shares 15.15M 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-060455
us-gaap PayablesToBrokerDealersAndClearingOrganizations Payables to Broker-Dealers and Clearing Organizations USD 0 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-482716
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 14.94M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-002926
us-gaap PaymentsForPurchaseOfSecuritiesOperatingActivities Payments for Purchase of Securities, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 289.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 1,128 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-01 0001193125-13-086681
us-gaap PaymentsOfDividends Payments of Dividends USD 7.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-083549
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 449.67M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030305
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 912.76M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001193125-15-284630
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 157.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 605.80M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001193125-15-284630
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 451.17M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030305
us-gaap ProceedsFromSaleOfSecuritiesOperatingActivities Proceeds from Sale of Securities, Operating Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap ProfessionalFees Professional Fees USD 1.50M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-08 0001564590-17-016089
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 10.66M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-191863
us-gaap RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments USD 257.20M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-05 0001564590-21-054593
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 135.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap ReceivablesFromBrokersDealersAndClearingOrganizations Receivables from Brokers-Dealers and Clearing Organizations USD 4,801 2021-09-30 2021 Q3 10-Q 2021-11-05 0001564590-21-054593
us-gaap ReceivablesFromClearingOrganizations Receivables from Clearing Organizations USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 47.61M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023715
us-gaap RestrictedCashAndInvestments Restricted Cash and Investments USD 308.67M 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-482716
us-gaap RestrictedInvestments Restricted Investments USD 90.00M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap RestrictedInvestmentsPercentOfNetAssets Restricted Investments, Percent of Net Assets pure 0.234 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-482716
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 64.99M 2012-09-30 2012 Q3 10-Q 2012-11-02 0001193125-12-448423
us-gaap SharesIssued Shares, Issued shares 26.00M 2012-09-30 2012 Q3 10-Q 2012-11-02 0001193125-12-448423
us-gaap SharesOutstanding Shares, Outstanding shares 13.00M 2013-09-30 2013 Q3 10-Q 2013-11-05 0001193125-13-427845
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 260.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD 56.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.80M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001193125-13-427845
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares -16.80M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001193125-13-427845
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 157.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -11.18M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-191863
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD -516,214 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-191863
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 200,000 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-191863
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 289.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net USD -119.29M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap TradeReceivablesHeldForSaleAmount Accounts Receivable, Held-for-sale USD 1.32M 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-105197
us-gaap TreasuryStockValue Treasury Stock, Value USD 2.00M 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080640
us-gaap UnrealizedGainLossOnCommodityContracts Unrealized Gain (Loss) on Commodity Contracts USD 46.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -60.10M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 46.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450267
us-gaap UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments Unrealized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments USD -17.37M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-05 0001564590-21-054593
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 14,107 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090
us-gaap UnrealizedGainOnSecurities Unrealized Gain on Securities USD 15.06M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001193125-13-427845
us-gaap UnrealizedLossOnSecurities Unrealized Loss on Securities USD 486,320 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001193125-13-427845
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001193125-15-370090

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →